Economic evidence for social prescribing remains limited
Some evaluations reported positive social returns, but few used standard economic methods, making decisions about funding difficult.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
This review examined how social prescribing programs have been evaluated economically, rather than estimating a single health benefit. Some analyses reported positive social returns for programs addressing mental health and loneliness. However, established economic methods were rarely used, leaving limited robust evidence to guide healthcare planning or decisions about which services to fund.
The abstract gives no return estimates, cost figures, or detailed comparator information. Reported positive social returns therefore cannot be translated into a specific financial saving or patient health benefit.
What the programs involved
Social prescribing connects people with community support, which can include activities, social groups, or practical advice. Included evaluations covered exercise and loneliness initiatives, coaching, nature programs, and dance or movement programs.
What positive returns mean here
The positive findings came from Social Return on Investment analyses focused on mental health and loneliness. The abstract provides no numerical estimates or calculation details, so the basis and size of those returns remain unclear.
The original publication
The health economics of social prescribing: systematic review of the international evidence.
Lynch M, Keating AJ, Morrow E et al.
Front Public Health · 2026
- PubMed ID
- 41684396
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.